Aurobindo Pharma shares soar over 13% post Q4 earnings

Shares of Aurobindo Pharma today jumped over 13 per cent even as the company posted a 4 per cent dip in consolidated net profit for the fourth quarter ended March 2017.
The stock surged 12.94 per cent to end at Rs 580.15 on BSE. During the day, it soared 13.68 per cent to Rs 584.
At NSE, shares of the company zoomed 13.25 per cent to close at Rs 580.30.
Following the sharp surge in the stock, the company's market valuation went up by Rs 3,893.97 crore to Rs 33,989.97 crore.
In terms of volume, 20.55 lakh shares of the company were traded on BSE and over one crore shares changed hands at NSE during the day.

Aurobindo Pharma yesterday posted a 4 per cent dip in consolidated net profit at Rs 532.22 crore for the fourth quarter ended March 2017.

The company had posted a net profit of Rs 554.51 crore during the same period of the previous fiscal.
Total income was lower by 2.6 per cent for the fourth quarter at Rs 3,682.41 crore, as compared to Rs 3,782.3 crore in the same period of previous fiscal, Aurobindo Pharma said in a regulatory filing.
For the full year, the company saw net profit rising 13.7 per cent at Rs 2,301.2 crore, while total income was up 7.3 per cent to Rs 15,205.75 crore over the previous fiscal.

The Board of Directors has approved a second interim dividend of Rs 1.25 per equity share of Re 1 for the financial year 2016-17.